NKD2 AS TARGET FOR TREATING RENAL FIBROSIS Application WO-2022090434-A1 World Intellectual Property Organisation (WIPO) 05 May 2022
Methods and monitoring of treatment with a WNT pathway inhibitor Grant US-9987357-B2 United States of America 05 Jun 2018
Methods of treating cancer by administering a soluble receptor comprising a human Fc… Grant US-9732139-B2 United States of America 15 Aug 2017
Wnt antagonist and methods of treatment and screening Grant US-9579361-B2 United States of America 28 Feb 2017